Two replicate phase 3 trials of GB-0895, an anti-thymic stromal lymphopoietin antibody, are enrolling adults and adolescents ...

As flu cases rise across the U.S., those who end up contracting the virus have treatments available that may help reduce ...

Dupilumab, a fully human monoclonal antibody, inhibits the signaling of the interleukin 4 (IL-4) and IL-13 pathways.

This year’s top asthma and respiratory disorder story focused on the pushback from multiple advocacy groups following ...

Asthma and allergic diseases are among the most prevalent non-communicable disorders globally, arising from multifaceted interactions between host immunity, ...

Aetna agreed in a landmark legal settlement to cover fertility treatments for same-sex couples the same way as it does for ...

Take steps to reduce stress and anxiety: Meditation, deep-breathing exercises and leisure activities you enjoy will help ...

New ‘life-changing’ asthma drug gets green light after rise in hospital admissions - A trial cut hospital admissions by 72 ...

The injectable therapy contain antibodies that dampen inflammation in the lungs and is set to revolutionise the way severe ...

An asthma treatment that only requires patients to have two jabs a year to prevent life-threatening attacks will be available ...

Tezepelumab may allow patients with severe, uncontrolled asthma who are oral corticosteroid-dependent to decrease their OCS use.

The U.S. Food and Drug Administration has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe ...